Lv42
408 积分 2026-05-11 加入
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
4小时前
待确认
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
4小时前
已完结
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
5小时前
已完结
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
5小时前
已完结
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
23小时前
已完结
皖公网安备34019202002308
